Cargando…
Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States
BACKGROUND: Asthma is the most common inflammatory lung disease in the United States. Since 2015, biologic therapies have provided targeted treatment for patients with severe asthma. OBJECTIVE: To evaluate the trends for in-hospital outcomes of asthma before (2012-2014) and after (2016-2018) the int...
Autores principales: | Kang, Hye-Rim, Hernandez-Con, Pilar, Heo, Ji Haeng, Wilson, Debbie L, Blake, Kathryn V, Lang, Jason E, Park, Haesuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388017/ https://www.ncbi.nlm.nih.gov/pubmed/37404074 http://dx.doi.org/10.18553/jmcp.2023.29.7.721 |
Ejemplares similares
-
Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States
por: Song, Hyun Jin, et al.
Publicado: (2020) -
Health-Related Quality of Life and Health Utilities of Mild, Moderate, and Severe Asthma: Evidence from the Medical Expenditure Panel Survey
por: Song, Hyun Jin, et al.
Publicado: (2021) -
Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States
por: Park, Haesuk, et al.
Publicado: (2023) -
Role of biomarkers in understanding and treating children with asthma: towards personalized care
por: Lang, Jason E, et al.
Publicado: (2013) -
Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
por: Park, Haesuk, et al.
Publicado: (2022)